封面
市場調查報告書
商品編碼
1775380

醫療包裝薄膜市場:未來預測(2025-2030)

Medical Packaging Films Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計醫療包裝薄膜市場規模將從 2025 年的 85.44 億美元成長到 2030 年的 117.63 億美元,複合年成長率為 6.60%。

由於對生物技術注射藥物的需求不斷成長以及醫療和製藥行業的不斷擴張,醫用包裝薄膜市場正在經歷強勁成長。這些藥物通常對熱敏感,需要能夠確保產品保護、品質、防篡改和患者安全的包裝解決方案,而無需依賴高溫末端穩定製程。醫用包裝薄膜在滿足這些需求並為藥品包裝提供可靠且高效的解決方案方面發揮關鍵作用。

市場促進因素

  • 政府措施和醫療保健投資

政府對先進醫療系統的投資是醫用包裝薄膜市場的主要驅動力。例如,在韓國,超過一半的醫療支出由國家和州政府資助,國民健康保險 (NHI) 涵蓋約 96% 的人口,佔醫療總支出的近一半。這提高了醫療服務的可用性和可近性,刺激了對醫療包裝解決方案的需求。同樣,在澳大利亞,醫療保健支出預計將在 2024 年達到 1,810 億美元,年增 6%,其中超過三分之二由聯邦和州政府資助。醫療保險福利計劃 (MBS) 和藥品福利計劃 (PBS) 等項目津貼基層醫療並吸引私人投資於醫療設備和包裝。預計這些政策將透過鼓勵創新和採用先進的包裝解決方案來推動未來五年的市場成長。

市場區隔

  • 聚丙烯的優點

聚丙烯 (PP) 憑藉其環保特性和優異的防潮性能,在醫藥包裝行業中獲得了廣泛認可,佔據了相當大的市場佔有率。在歐洲等法律限制焚燒聚氯乙烯( PVC) 的地區,PP 正逐漸取代聚氯乙烯 (PVC)。 PP 適用於泡殼包裝,其強大的防潮性能也促使其在醫藥應用領域廣泛採用。例如,主要企業(SIBUR) 推出了一種基於 PP 的新型包裝解決方案,該解決方案採用了專為醫藥行業泡殼包裝量身定做的 Millad NX 8000。預計對 PP 的持續投資將進一步提升其在市場上的主導地位。

區域成長:亞太地區領先

亞太地區是醫療包裝薄膜市場的主要成長引擎,這得益於不斷提升的健康意識以及公共和私營部門的大量投資。該地區擁有一些全球最大的醫藥包裝公司,並受益於豐富的原料和低廉的生產成本。

本報告的主要優點

  • 深刻分析:獲得涵蓋主要地區和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要企業採取的策略策略,並了解正確策略帶來的潛在市場滲透。
  • 市場促進因素和未來趨勢:探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議:利用洞察力進行策略決策,在動態環境中開闢新的業務流和收益。
  • 適用範圍廣:對於新興企業、研究機構、顧問公司、中小企業和大型企業來說,它都是實用且具有成本效益的。

它有什麼用途?

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料(2022-2024)和預測資料(2025-2030)
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按部門和地區(國家)分類的收益成長和預測分析
  • 公司概況(策略、產品、財務資訊、主要趨勢等)

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 法律規範
  • 策略建議

第4章 技術展望

第5章 全球醫用包裝薄膜市場(依材料)

  • 介紹
  • 聚丙烯(PP)
  • 聚乙烯(PE)
  • 聚醯胺(PA)
  • 生物分解性/生物基薄膜(例如 PLA、PHA)
  • 其他

6 全球醫用包裝薄膜市場依薄膜類型分類

  • 介紹
  • 熱成型膜
  • 高阻隔膜
  • 無菌阻隔膜
  • 其他

第7章全球醫用包裝薄膜市場應用

  • 介紹
  • 包包
  • 管子
  • 泡殼包裝
  • 袋子和蓋子
  • 其他

8. 全球醫療包裝薄膜市場(依最終用戶)

  • 介紹
  • 製藥公司
  • 醫療設備製造商
  • 醫院和診所

9. 全球醫療包裝薄膜市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章 競爭格局

  • 主要企業和策略分析
  • 市場佔有率分析
  • 企業合併(M&A)、協議與合作
  • 競爭儀錶板

第11章 公司簡介

  • Amcor plc
  • DuPont de Nemours, Inc.
  • Berry Global Group, Inc.
  • 3M Company
  • Honeywell International LLC
  • Wipak Oy
  • Renolit SE
  • Weigao Group
  • Covestro AG
  • POLYCINE GmbH
  • Sealed Air Corporation

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061613424

The Medical Packaging Films Market is expected to grow from USD 8.544 billion in 2025 to USD 11.763 billion in 2030, at a CAGR of 6.60%.

The medical packaging films market is experiencing robust growth, driven by the increasing demand for biotechnology-based injectable drugs and expanding healthcare and pharmaceutical sectors. These drugs, often heat-sensitive, require packaging solutions that ensure product protection, quality, tamper-evidence, and patient safety without relying on high-heat terminal stabilization processes. Medical packaging films are critical in meeting these needs, offering reliable and efficient solutions for pharmaceutical packaging.

Market Growth Drivers

  • Government Initiatives and Healthcare Investment

Government investments in advanced healthcare systems are a key driver of the medical packaging films market. In South Korea, for instance, over half of healthcare spending is funded by national and state governments, with the National Healthcare Insurance (NHI) covering approximately 96% of the population and nearly half of total healthcare costs. This enhances affordability and access to healthcare services, spurring demand for medical packaging solutions. Similarly, in Australia, healthcare spending reached $181 billion in 2024, a 6% increase from the previous year, with over two-thirds funded by federal and state governments. Programs like the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS) subsidize primary care and ensure affordability, attracting private investment in medical equipment and packaging. These policies are expected to drive market growth over the next five years by fostering innovation and adoption of advanced packaging solutions.

Market Segment Analysis

  • Dominance of Polypropylene

Polypropylene (PP) is gaining significant traction in the pharmaceutical packaging industry, holding a substantial market share due to its eco-friendly properties and excellent moisture-barrier capabilities. It is increasingly replacing polyvinyl chloride (PVC) in regions like Europe, where legislation restricts PVC incineration. PP's suitability for blister packaging, which provides robust moisture protection, has fueled its adoption in pharmaceutical applications. For example, SIBUR, a leading Russian company, introduced new PP-based packaging solutions incorporating Millad NX 8000, tailored for blister packaging in the pharmaceutical sector. Continued investments in PP are expected to further bolster its dominance in the market.

Regional Growth: Asia Pacific Leading the Way

The Asia Pacific region is a major growth engine for the medical packaging films market, driven by rising health awareness and significant investments from both public and private sectors. The region hosts some of the world's largest pharmaceutical packaging companies, benefiting from abundant raw materials and low production costs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Key Market Segmentation:

By Material

  • Polypropylene (PP)
  • Polyethene (PE)
  • Polyamide (PA)
  • Biodegradable/Bio-based Films (e.g., PLA, PHA)
  • Others

By Film Type

  • Thermoformable Films
  • High Barrier Films
  • Sterile Barriers films
  • Others

By Application

  • Bags
  • Tubes
  • Blister Packs
  • Pouches & Lidding Films
  • Others

By End-User

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Hospitals & Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Regulatory Framework
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICAL PACKAGING FILMS MARKET BY MATERIAL

  • 5.1. Introduction
  • 5.2. Polypropylene (PP)
  • 5.3. Polyethene (PE)
  • 5.4. Polyamide (PA)
  • 5.5. Biodegradable/Bio-based Films (e.g., PLA, PHA)
  • 5.6. Others

6. GLOBAL MEDICAL PACKAGING FILMS MARKET BY FILM TYPE

  • 6.1. Introduction
  • 6.2. Thermoformable Films
  • 6.3. High Barrier Films
  • 6.4. Sterile Barriers Films
  • 6.5. Others

7. GLOBAL MEDICAL PACKAGING FILMS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Bags
  • 7.3. Tubes
  • 7.4. Blister Packs
  • 7.5. Pouches & Lidding Films
  • 7.6. Others

8. GLOBAL MEDICAL PACKAGING FILMS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceutical Companies
  • 8.3. Medical Device Manufacturers
  • 8.4. Hospitals & Clinics

9. GLOBAL MEDICAL PACKAGING FILMS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE LANDSCAPE

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Amcor plc
  • 11.2. DuPont de Nemours, Inc.
  • 11.3. Berry Global Group, Inc.
  • 11.4. 3M Company
  • 11.5. Honeywell International LLC
  • 11.6. Wipak Oy
  • 11.7. Renolit SE
  • 11.8. Weigao Group
  • 11.9. Covestro AG
  • 11.10. POLYCINE GmbH
  • 11.11. Sealed Air Corporation

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations